Systematic Review and Meta-Analysis: Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Liver Disease

Ayesha Shah1,2,3, Erin Shanahan1,3, Graeme A Macdonald1,2,3

  • 1Faculty of Medicine, Princess Alexandra Hospital, The University of Queensland, Brisbane, Queensland, Australia.

Seminars in Liver Disease
|December 23, 2017
PubMed

Insights

Small intestinal bacterial overgrowth (SIBO) is significantly more prevalent in patients with chronic liver disease (CLD). This association suggests SIBO may contribute to CLD progression, not just result from advanced disease.

Area of Science:

  • Gastroenterology
  • Hepatology
  • Microbiology

Background:

  • Small intestinal bacterial overgrowth (SIBO) is a condition characterized by excessive bacteria in the small intestine.
  • Chronic liver disease (CLD) encompasses a range of conditions affecting liver function over time.
  • The relationship between SIBO and CLD requires further elucidation.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the prevalence of SIBO in patients with CLD compared to controls.
  • To investigate whether SIBO is associated with the severity of chronic liver disease.

Main Methods:

  • A systematic literature search was performed using keywords related to SIBO and CLD.
  • Nineteen case-control studies were included in the meta-analysis.
  • Prevalence data were analyzed using breath tests and culture techniques.

Main Results:

  • SIBO prevalence was significantly higher in CLD patients (35.80% by breath test, 68.31% by culture) compared to controls (8.0% and 7.94%, respectively).
  • No significant difference in SIBO prevalence was observed between cirrhotic and non-cirrhotic CLD patients.
  • The findings indicate a strong association between SIBO and CLD, irrespective of disease advancement.

Conclusions:

  • SIBO is significantly more frequent in patients with chronic liver disease.
  • The presence of SIBO in CLD patients suggests it may play a role in disease progression rather than being solely a consequence of advanced liver disease.
  • Further research is warranted to explore the causative role of SIBO in CLD pathogenesis.

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
817
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
915
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
649
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.4K
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.7K